Finance

Beta
Lists
GHRS:NASDAQ
GH Research PLC
$26.11
-4.01%
(-1.09) 1D
Jul 10, 10:22:40 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GHRS...
Open
$27.36
High
$27.88
Low
$26.11
Mkt. cap
1.81B
Avg. vol.
258.66K
Volume
33.21K
52-wk high
$28.96
52-wk low
$11.32
EPS
-$0.91
Beta
1.29
Shares outstanding
68.56M
No. of employees
73
Open
$27.36
High
$27.88
Low
$26.11
Mkt. cap
1.81B
Avg. vol.
258.66K
Volume
33.21K
52-wk high
$28.96
52-wk low
$11.32
EPS
-$0.91
Beta
1.29
Shares outstanding
68.56M
No. of employees
73
News stories
From sources across the web
About GH Research PLC
CEOTheis Terwey
Employees73
Founded2018
Headquarters-
SectorPharmaceutical industry
Websiteghres.com
Analyst ratings
Based on 7 analysts giving stock ratings to GHRS in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for GHRS in the last 3 months.
Highest
Current $26.11
$65.00 (+148.95%)
Average
$41.67 (+59.59%)
Lowest
$32.00 (+22.56%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$65.00
+148.9%
05/19/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$35.00
+34%
05/15/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$39.00
+49.4%
05/15/2026
Jason Butler
Citizens JMP
Buy
Maintained
$39.00
+49.4%
05/15/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
05/14/2026
Ami Fadia
Needham
Buy
Reiterated
$32.00
+22.6%
05/15/2026
Brian Abrahams
RBC Capital
Buy
Maintained
$40.00
+53.2%
05/14/2026
Eddie Hickman
Guggenheim
Buy
Maintained
$34.00
+30.2%
03/09/2026
Paul Matteis
Stifel Nicolaus
Buy
Reiterated
$32.00
+22.6%
03/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8.96M
10.57M
11.39M
12.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.75M
6.00M
5.33M
6.37M
Operating expense
14.69M
16.54M
16.70M
18.75M
Total operating expenses
14.69M
16.54M
16.70M
18.75M
Operating income
-14.69M
-16.54M
-16.70M
-18.75M
Other non operating income
-
-
-
-
EBT including unusual items
-9.29M
-14.02M
-14.14M
-18.97M
EBT excluding unusual items
-11.11M
-15.80M
-15.84M
-20.50M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.29M
-14.02M
-14.14M
-18.97M
Net profit margin
-
-
-
-
Earnings per share
-0.15
-0.23
-0.22
-0.31
Interest and investment income
1.26M
1.00M
812.00K
666.00K
Interest expense
-174.00K
-21.00K
-90.00K
-84.00K
Net interest expenses
1.08M
980.00K
722.00K
582.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.61M
-16.45M
-16.68M
-18.66M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer